ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
81,986.93
1.17%
S&P 500
5,521.52
-1.39%
Dow Jones
40,813.57
-1.30%
US Dollar vs Yen
148.5155
0.38%
Brent Oil
70.09
0.24%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Prevail Therapeutics Inc (PRVL)

  7. Prevail Therapeutics Inc (PRVL) ニュース

PRVL

Prevail Therapeutics (PRVL)

Prevail Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PRVL
日付受信時刻ニュースソース見出しコード企業名
2021/02/1706 : 43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVLPrevail Therapeutics Inc
2021/02/1706 : 36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVLPrevail Therapeutics Inc
2021/02/1306 : 31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVLPrevail Therapeutics Inc
2021/02/1306 : 08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVLPrevail Therapeutics Inc
2021/02/0120 : 41Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/3006 : 16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2920 : 13Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2720 : 12Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2707 : 20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2707 : 19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2707 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2707 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2707 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2707 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2707 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2707 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2707 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2707 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2306 : 39Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2306 : 26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2223 : 26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2223 : 03Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2223 : 03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2222 : 55PR Newswire (US)Lilly Completes Acquisition of Prevail TherapeuticsNASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2021 : 01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/2020 : 44Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/0522 : 29Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRVLPrevail Therapeutics Inc
2021/01/0521 : 55Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRVLPrevail Therapeutics Inc
2020/12/2222 : 50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRVLPrevail Therapeutics Inc
2020/12/2222 : 34Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:PRVLPrevail Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PRVL

最近閲覧した銘柄

AMEX
DIVI
Franklin International C...
EU
AXHLE
AXA Home Loan SFH 0.11% ...
AMEX
FAN
First Trust Global Wind ...
LSE
0IND
First Trust Dow Jones In...
TSXV
ENTG
Entourage Health
EU
CSBTN
CAC Climate Transition NR
BIT
CLWD
Exchange Traded
TG
A193A8
P and V Assurances Scrl
TSXV
SLG
San Lorenzo Gold
TG
A2R68L
Siemens
COIN
ARIA20ETH
ARIANEE
AMEX
DRIP
Direxion Daily S&P Oil &...
NYSE
AMTM
Amentum
LSE
HUMA
Hummingbird Resources
LSE
WKS
Winking Studios
TG
A3LA6E
Agence France
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す